China Health Care Stock Buy Hold or Sell Recommendation

CMIM Stock  USD 0.0002  0.00  0.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding China Health Care is 'Strong Sell'. Macroaxis provides China Health buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CMIM positions. The advice algorithm takes into account all of China Health's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting China Health's buy or sell advice are summarized below:
Real Value
0.000168
Hype Value
0.0002
Market Value
0.0002
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell China Health Care given historical horizon and risk tolerance towards China Health. When Macroaxis issues a 'buy' or 'sell' recommendation for China Health Care, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out China Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as China and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards China Health Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

Execute China Health Buy or Sell Advice

The China recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on China Health Care. Macroaxis does not own or have any residual interests in China Health Care or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute China Health's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell China HealthBuy China Health
Not Rated
For the selected time horizon China Health Care has a Return On Asset of -0.73, Operating Margin of (3.87) %, Current Valuation of 9.03 M, Shares Outstanding of 4.18 M, Price To Sales of 0.01 X and Revenue of 545.88 K
We provide trade advice to complement the prevailing expert consensus on China Health Care. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure China Health is not overpriced, please confirm all China Health Care fundamentals, including its ebitda and the relationship between the total debt and total asset . As China Health Care appears to be a penny stock we also recommend to validate its revenue numbers.

China Health Trading Alerts and Improvement Suggestions

China Health Care generated a negative expected return over the last 90 days
China Health Care has some characteristics of a very speculative penny stock
China Health Care has high likelihood to experience some financial distress in the next 2 years
The company currently holds 3.11 M in liabilities. China Health Care has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist China Health until it has trouble settling it off, either with new capital or with free cash flow. So, China Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Health Care sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Health's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 545.88 K. Net Loss for the year was (2.7 M) with profit before overhead, payroll, taxes, and interest of 377.77 K.
China Health Care currently holds about 26.63 K in cash with (1.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

China Health Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to China Health or Basic Materials sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that China Health's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a China pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.00
β
Beta against NYSE Composite0.00
σ
Overall volatility
0.00
Ir
Information ratio 0.00

China Health Volatility Alert

At this time China Health Care exhibits very low volatility. China Health Care appears to be a penny stock. Although China Health Care may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in China Health Care or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on China instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

China Health Fundamentals Vs Peers

Comparing China Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze China Health's direct or indirect competition across all of the common fundamentals between China Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as China Health or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of China Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing China Health by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare China Health to competition
FundamentalsChina HealthPeer Average
Return On Asset-0.73-0.14
Operating Margin(3.87) %(5.51) %
Current Valuation9.03 M16.62 B
Shares Outstanding4.18 M571.82 M
Price To Sales0.01 X11.42 X
Revenue545.88 K9.43 B
Gross Profit377.77 K27.38 B
EBITDA(1.31 M)3.9 B
Net Income(2.7 M)570.98 M
Cash And Equivalents26.63 K2.7 B
Cash Per Share0.01 X5.01 X
Total Debt3.11 M5.32 B
Current Ratio0.08 X2.16 X
Book Value Per Share(1.35) X1.93 K
Cash Flow From Operations(1.46 M)971.22 M
Earnings Per Share(0.29) X3.12 X
Number Of Employees1418.84 K
Beta0.68-0.15
Market Capitalization2.53 K19.03 B
Total Asset1.5 M29.47 B
Annual Yield0.12 %
Net Asset1.5 M

China Health Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as China . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About China Health Buy or Sell Advice

When is the right time to buy or sell China Health Care? Buying financial instruments such as China Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having China Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Education Thematic Idea Now

Education
Education Theme
Companies involved in apprenticeship, education, tutoring, schooling, online universities, and other learning services. The Education theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Education Theme or any other thematic opportunities.
View All  Next Launch
Check out China Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for China Pink Sheet analysis

When running China Health's price analysis, check to measure China Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Health is operating at the current time. Most of China Health's value examination focuses on studying past and present price action to predict the probability of China Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Health's price. Additionally, you may evaluate how the addition of China Health to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stocks Directory
Find actively traded stocks across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Please note, there is a significant difference between China Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.